RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104 | -33.3% | 12,397 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $156 | -23.5% | 12,397 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $204 | +10.3% | 12,397 | 0.0% | 0.02% | +6.7% |
| Q4 2022 | $185 | -99.9% | 12,397 | -2.7% | 0.02% | -40.0% |
| Q3 2022 | $286,000 | +33.6% | 12,747 | 0.0% | 0.02% | +38.9% |
| Q2 2022 | $214,000 | -44.0% | 12,747 | 0.0% | 0.02% | -33.3% |
| Q1 2022 | $382,000 | -2.3% | 12,747 | 0.0% | 0.03% | +8.0% |
| Q4 2021 | $391,000 | 0.0% | 12,747 | +2.8% | 0.02% | -10.7% |
| Q3 2021 | $391,000 | -49.4% | 12,397 | -41.3% | 0.03% | -49.1% |
| Q2 2021 | $773,000 | +5.9% | 21,121 | 0.0% | 0.06% | 0.0% |
| Q1 2021 | $730,000 | -16.9% | 21,121 | 0.0% | 0.06% | -19.1% |
| Q4 2020 | $878,000 | -2.4% | 21,121 | 0.0% | 0.07% | -17.1% |
| Q3 2020 | $900,000 | – | 21,121 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |